An analysis of leukapheresis and central venous catheter use in the randomized, placebo controlled, phase 3 IMPACT trial of sipuleucel-T for metastatic castrate resistant prostate cancer

Journal of Urology

Volumn 189, Issue 2, 2013, Pages 521-526

  Flanigan, Robert C ^a   Polcari, Anthony J ^a   Shore, Neil D ^b   Price, Thomas H ^c   Sims, Robert B ^d   Maher, Johnathan C ^d   Whitmore, James B ^d   Corman, John M ^e  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b Atlantic Urology Clinics   (United States)

^c PUGET SOUND BLOOD CENTER   (United States)

^d Dendreon   (United States)

^e VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

catheters; immunotherapy; leukapheresis; prostatic neoplasms; sipuleucel T

Indexed keywords

CALCIUM; PLACEBO; SIPULEUCEL T;

ADULT; ANEMIA; ARTHRALGIA; ARTICLE; BACKACHE; BLOOD VOLUME; CANCER CHEMOTHERAPY; CASTRATION RESISTANT PROSTATE CANCER; CENTRAL VENOUS CATHETER; CHILL; CITRATE TOXICITY; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG INTOXICATION; FATIGUE; HUMAN; HYPOCALCEMIA; HYPOTENSION; IMMUNOCOMPETENT CELL; INFECTION COMPLICATION; INFECTION RISK; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANDROGEN ANTAGONISTS; CATHETERIZATION, CENTRAL VENOUS; COMBINED MODALITY THERAPY; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKAPHERESIS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; TISSUE EXTRACTS; VACCINATION;

EID: 84872140894     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.09.029     Document Type: Article

References (24)

1. R. Siegel, D. Naishadham, A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10
2. K.A. Roehl, M. Han, C.G. Ramos Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results J Urol 172 2004 910
3. E.S. Antonarakis, M.A. Eisenberger Expanding treatment options for metastatic prostate cancer N Engl J Med 364 2011 2055
4. P.W. Kantoff, C.S. Higano, N.D. Shore Sipuleucel-T immunotherapy for castration-resistant prostate cancer N Engl J Med 363 2010 411
5. C.D. Bolan, S.F. Leitman Management of anticoagulation-associated toxicity during large-volume leukapheresis of peripheral blood stem cell donors Blood 99 2002 1878
6. L. Uhl, S. Maillet, S. King Unexpected citrate toxicity and severe hypocalcemia during apheresis Transfusion 37 1997 1063
7. D.C. McGee, M.K. Gould Preventing complications of central venous catheterization N Engl J Med 348 2003 1123
8. E.J. Small, P. Fratesi, D.M. Reese Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells J Clin Oncol 18 2000 3894
9. E.J. Small, P.F. Schellhammer, C.S. Higano Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer J Clin Oncol 24 2006 3089
10. T.R. Fleming Identifying and addressing safety signals in clinical trials N Engl J Med 359 2008 1400
11. E.E. Osgood Number and distribution of human hemic cells Blood 9 1954 1141
12. M. Di Mascio, C.H. Paik, J.A. Carrasquillo Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates Blood 114 2009 328
13. F. Trepel Number and distribution of lymphocytes in man A critical analysis Klin Wochenschr 52 1974 511
14. J. Sprent, J.H. Cho, O. Boyman T cell homeostasis Immunol Cell Biol 86 2008 312
15. E.F. Strasser, R. Zimmermann, V. Weisbach Mononuclear cell variability and recruitment in non-cytokine-stimulated donors after serial 10-liter leukapheresis procedures Transfusion 45 2005 445
16. R.G. Strauss Effects on donors of repeated leukocyte losses during plateletpheresis J Clin Apher 9 1994 130
17. J.M. Heal, P.K. Horan, T.C. Schmitt Long-term follow-up of donors cytapheresed more than 50 times Vox Sang 45 1983 14
18. F. Orsini, J. Fitzpatrick, E. Cohen Effects of source leukocyte collection on the immune system Vox Sang 43 1982 11
19. V.S. Blanchette, J. Dunne, D. Steele Immune function in blood donors following short-term lymphocytapheresis Vox Sang 49 1985 101
20. B.C. McLeod, I. Sniecinski, D. Ciavarella Frequency of immediate adverse effects associated with therapeutic apheresis Transfusion 39 1999 282
21. S.J. Hall, L. Klotz, A.J. Pantuck Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer J Urol 186 2011 877
22. B.C. McLeod Apheresis: Principles and Practice 2nd ed. 2003 AABB Press Bethesda 261
23. J.D. Roback, M.R. Combs, B.J. Grossman Technical Manual 16th ed. 2008 AABB Press Bethesda 162 193
24. D.G. Maki, D.M. Kluger, C.J. Crnich The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies Mayo Clin Proc 81 2006 1159